Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oseltamivir phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oseltamivir 75mg capsules
0503040B0AAAAAA
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 2,060 |
|
Oseltamivir 30mg capsules
0503040B0AAACAC
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 1,148 |
|
Tamiflu 75mg capsules
0503040B0BBAAAA
|
Tamiflu | Oseltamivir phosphate | Infections | 399 |
|
Tamiflu 30mg capsules
0503040B0BBACAC
|
Tamiflu | Oseltamivir phosphate | Infections | 186 |
|
Oseltamivir 6mg/ml oral suspension sugar free
0503040B0AAAGAG
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 86 |
|
Tamiflu 6mg/ml oral suspension
0503040B0BBAEAG
|
Tamiflu | Oseltamivir phosphate | Infections | 18 |
|
Oseltamivir 45mg capsules
0503040B0AAADAD
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 8 |
|
Ebilfumin 75mg capsules
0503040B0BCAAAA
|
Ebilfumin | Oseltamivir phosphate | Infections | 1 |
|
Oseltamivir 15mg/ml oral liquid
0503040B0AAAEAE
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Oseltamivir 15mg/ml oral solution sugar free
0503040B0AAAFAF
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Oseltamivir 60mg/5ml oral suspension sugar free
0503040B0AAABAB
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Tamiflu 12mg/ml oral suspension
0503040B0BBABAB
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
|
Tamiflu 45mg capsules
0503040B0BBADAD
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.